Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Repurposing mebendazole against triple-negative breast cancer leptomeningeal disease.
Rodrigues A, Chernikova SB, Wang Y, Trinh TTH, Solow-Cordero DE, Alexandrova L, Casey KM, Alli E, Aggarwal A, Quill T, Koegel A, Feldman BJ, Ford JM, Hayden-Gephart M. Rodrigues A, et al. Among authors: chernikova sb. Res Sq [Preprint]. 2024 Feb 5:rs.3.rs-3915392. doi: 10.21203/rs.3.rs-3915392/v1. Res Sq. 2024. PMID: 38405839 Free PMC article. Updated. Preprint.
Repurposing mebendazole against triple-negative breast cancer CNS metastasis.
Rodrigues AJ, Chernikova SB, Wang Y, Trinh TTH, Solow-Cordero DE, Alexandrova L, Casey KM, Alli E, Aggarwal A, Quill T, Koegel AK, Feldman BJ, Ford JM, Hayden-Gephart M. Rodrigues AJ, et al. Among authors: chernikova sb. J Neurooncol. 2024 May;168(1):125-138. doi: 10.1007/s11060-024-04654-x. Epub 2024 Apr 2. J Neurooncol. 2024. PMID: 38563850 Free PMC article.
Correction: Macrophage Exclusion after Radiation Therapy (MERT): A First-in-Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.
Thomas RP, Nagpal S, Iv M, Soltys SG, Bertrand S, Pelpola JS, Ball R, Yang J, Sundaram V, Chernikova SB, Lavezo J, Born D, Vogel H, Brown JM, Recht LD. Thomas RP, et al. Among authors: chernikova sb. Clin Cancer Res. 2023 Jan 17;29(2):502. doi: 10.1158/1078-0432.CCR-22-3712. Clin Cancer Res. 2023. PMID: 36647675 No abstract available.
A Novel Brain-Permeant Chemotherapeutic Agent for the Treatment of Brain Metastasis in Triple-Negative Breast Cancer.
Deng J, Chernikova SB, Wang Y, Rodriguez ML, Andersen SJ, Umeh-Garcia MC, Godfrey BO, Ahmadian SS, Fischer WN, Koller KJ, Jandeleit B, Ringold GM, Gephart MH. Deng J, et al. Among authors: chernikova sb. Mol Cancer Ther. 2021 Nov;20(11):2110-2116. doi: 10.1158/1535-7163.MCT-21-0140. Epub 2021 Oct 11. Mol Cancer Ther. 2021. PMID: 34635566 Free PMC article.
Dynamin 2, cell trafficking, and the triple-negative paradox.
Chernikova SB, Game JC, Brown JM. Chernikova SB, et al. Oncotarget. 2019 Mar 22;10(24):2336-2337. doi: 10.18632/oncotarget.26778. eCollection 2019 Mar 22. Oncotarget. 2019. PMID: 31040924 Free PMC article. No abstract available.
Dynamin impacts homology-directed repair and breast cancer response to chemotherapy.
Chernikova SB, Nguyen RB, Truong JT, Mello SS, Stafford JH, Hay MP, Olson A, Solow-Cordero DE, Wood DJ, Henry S, von Eyben R, Deng L, Gephart MH, Aroumougame A, Wiese C, Game JC, Győrffy B, Brown JM. Chernikova SB, et al. J Clin Invest. 2018 Dec 3;128(12):5307-5321. doi: 10.1172/JCI87191. Epub 2018 Oct 29. J Clin Invest. 2018. PMID: 30371505 Free PMC article.
Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.
Walters MJ, Ebsworth K, Berahovich RD, Penfold ME, Liu SC, Al Omran R, Kioi M, Chernikova SB, Tseng D, Mulkearns-Hubert EE, Sinyuk M, Ransohoff RM, Lathia JD, Karamchandani J, Kohrt HE, Zhang P, Powers JP, Jaen JC, Schall TJ, Merchant M, Recht L, Brown JM. Walters MJ, et al. Among authors: chernikova sb. Br J Cancer. 2014 Mar 4;110(5):1179-88. doi: 10.1038/bjc.2013.830. Epub 2014 Jan 14. Br J Cancer. 2014. PMID: 24423923 Free PMC article.
24 results